This inventor holds 1 USPTO granted patent. Top assignee: The Hong Kong University of Science and Technology. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Jianchao Li
Introduction
Jianchao Li is a prominent inventor based in Sai Kung, China. He has made significant contributions to the field of biotechnology, particularly in the development of autophagy inhibitors. His work is crucial for advancing treatments for various diseases, including cancer.
Latest Patents
Jianchao Li holds a patent for autophagy inhibitors. The patent details recombinant peptides that are useful for inhibiting the function of autophagy-related 8 (Atg8) proteins. These recombinant peptides can be utilized in the preparation of imaging agents for monitoring autophagy in cells or subjects, as well as for treating autophagy-related diseases.
Career Highlights
Jianchao Li is affiliated with The Hong Kong University of Science and Technology, where he conducts research and develops innovative solutions in biotechnology. His work has garnered attention for its potential impact on medical treatments and diagnostics.
Collaborations
Some of his notable coworkers include Ruichi Zhu and Chao Wang. Their collaborative efforts contribute to the advancement of research in the field of autophagy and its implications for health.
Conclusion
Jianchao Li's innovative work in developing autophagy inhibitors showcases his commitment to advancing medical science. His contributions are vital for the future of treatments for diseases such as cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile